Author: Fanfan Zeng; Chan Dai; Pengcheng Cai; Jinbiao Wang; Lei Xu; Jianyu Li; Guoyun Hu; Lin Wang
Title: A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender. Document date: 2020_3_27
ID: a1pa6g5c_34
Snippet: In conclusion, in this study we detected and analyzed the SARS-CoV-2 IgG antibody of 331 patients and found that, compared with male patients, more female patients maintained a high level of IgG antibody after SARS-CoV-2 infection. And the production of IgG in female patients tended to be stronger than male patients in early phase of COVID-19. We propose here that our doctors and nurses should pay more attention to the patients whose IgG antibody.....
Document: In conclusion, in this study we detected and analyzed the SARS-CoV-2 IgG antibody of 331 patients and found that, compared with male patients, more female patients maintained a high level of IgG antibody after SARS-CoV-2 infection. And the production of IgG in female patients tended to be stronger than male patients in early phase of COVID-19. We propose here that our doctors and nurses should pay more attention to the patients whose IgG antibody were at low levels. And monitoring IgG antibody maybe a potential method to assess COVID-19 progression.
Search related documents:
Co phrase search for related documents- attention pay and female patient: 1, 2
- attention pay and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- attention pay and IgG production: 1
- attention pay and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9
- attention pay and male patient: 1
- attention pay and nurse doctor: 1
- attention pay and potential method: 1, 2
- early phase and female patient: 1, 2, 3, 4, 5
- early phase and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- early phase and IgG antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- early phase and IgG antibody high level: 1, 2, 3, 4
- early phase and IgG production: 1, 2, 3
- early phase and low level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- early phase and male patient: 1
- early phase and progression assess: 1, 2
- female patient and high level: 1, 2, 3, 4, 5
- female patient and IgG antibody: 1, 2, 3, 4
- female patient and IgG antibody high level: 1
- female patient and low level: 1, 2
Co phrase search for related documents, hyperlinks ordered by date